Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis. (Q50638983)
Jump to navigation
Jump to search
scientific article published on 22 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis. |
scientific article published on 22 August 2014 |
Statements
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis (English)
Renea A Taylor
David Clouston
Ania Sliwinski
Sally Hunter
Gillian Mitchell
Declan Murphy
Mark Frydenberg
David Pook
John Pedersen
Roxanne Toivanen
Hong Wang
Melissa Papargiris
Damien M Bolton